SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
22nd Jun 200910:18 amRNSHolding(s) in Company
15th May 20094:18 pmRNSDirector/PDMR Shareholding
13th May 200912:00 pmRNSHolding(s) in Company
30th Apr 20093:17 pmRNSBlocklisting Six Monthly Return
30th Apr 20097:00 amRNSInterim Management Statement
28th Apr 200911:27 amRNSHolding(s) in Company
6th Apr 200912:05 pmRNSDirectorate Change
26th Mar 20092:03 pmRNSAppointment of Broker
10th Mar 20093:39 pmRNSDirector/PDMR Shareholding
5th Feb 20097:00 amRNSInterim Results
22nd Jan 200910:50 amRNSHolding(s) in Company
16th Jan 20093:16 pmRNSHolding(s) in Company
15th Jan 20094:51 pmRNSHolding(s) in Company
29th Dec 20084:41 pmRNSSecond Price Monitoring Extn
29th Dec 20084:36 pmRNSPrice Monitoring Extension
18th Dec 200810:30 amRNSHolding(s) in Company
18th Dec 20087:00 amRNSTrading Statement
3rd Dec 20084:35 pmRNSPrice Monitoring Extension
27th Nov 20084:37 pmRNSPrice Monitoring Extension
11th Nov 20082:47 pmRNSHolding(s) in Company
3rd Nov 200811:44 amRNSHolding(s) in Company
29th Oct 200810:59 amRNSBlocklisting Interim Review
27th Oct 20087:00 amRNSInterim Management Statement
16th Oct 20082:29 pmRNSDirector/PDMR Shareholding
14th Oct 20087:00 amRNSAnnual Information Update
24th Sep 200810:42 amRNSAnnual Report and Accounts
16th Sep 200811:06 amRNSDirector Declaration
5th Sep 20085:43 pmRNSHolding(s) in Company
5th Sep 200812:12 pmRNSDirector/PDMR Shareholding
4th Sep 20087:00 amRNSPreliminary Results
18th Jul 20082:56 pmRNSDirector Declaration
4th Jul 20084:34 pmRNSDirector/PDMR Shareholding
1st Jul 20087:00 amRNSTrading Statement
19th Jun 200812:20 pmRNSNotice of Trading Statement
11th Jun 20082:30 pmRNSDirector/PDMR Shareholding
29th May 20083:27 pmRNSDirectorate Change
9th May 200811:26 amRNSHolding(s) in Company
1st May 20083:49 pmRNSBlock Listing Cancellation
29th Apr 200810:41 amRNSBlocklisting Interim Review
29th Apr 200810:34 amRNSBlocklisting Interim Review
29th Apr 20087:01 amRNSDirectorate Change
29th Apr 20087:01 amRNSInterim Management Statement
28th Apr 200810:49 amRNSNotice of IMS
11th Apr 200810:48 amRNSHolding(s) in Company
2nd Apr 20082:18 pmRNSDirector/PDMR Shareholding
17th Mar 200810:59 amRNSDirector/PDMR Shareholding
10th Mar 20089:41 amRNSChange of Address
7th Mar 20084:34 pmRNSDirector/PDMR Shareholding
4th Mar 200812:58 pmRNSHolding(s) in Company
22nd Feb 20084:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.